Eli Lilly (LLY)

Latest stories mapped to LLY

• 2026-09-18 Guggenheim raises Eli Lilly stock price target to $1,284 on drug growth
• 2026-09-18 Exclusive-US weighs allowing most pharma licensing deals with China, sources say
• 2026-09-17 Eli Lilly (LLY) Gets a Big Price Target Boost, Analysts See 20% Upside
• 2026-09-17 Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
• 2026-09-16 Twist Bioscience stock rises on Eli Lilly partnership deal
• 2026-09-16 Haleon takes advantage of GLP-1 side effects as US sales rise
• 2026-09-16 Twist Bio, and Gingko rise after agreements with Lilly TuneLab
• 2026-09-16 Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
• 2026-09-16 Twist Bioscience partners with Lilly TuneLab for AI drug discovery
• 2026-09-16 MannKind (MNKD) Bets On Inhaled Weight Loss Amid Widening Losses
• 2026-09-15 Lilly’s Foundayo Quickly Gains Ground in the Oral Weight-Loss Market
• 2026-09-15 BioNTech’s Lung Cancer Drug Shows Signs of a Major Breakthrough
• 2026-09-15 From Novo Nordisk to ‘Novo’: A Strategic Reset Amid Rising Lilly Pressure
• 2026-09-15 Eli Lilly boosted to Buy at Berenberg as upside to 2026 guidance seen
• 2026-09-15 There Are Plenty of Eli Lilly Bulls: Here’s What They Aren’t Telling You
• 2026-09-15 Lilly to present cardiometabolic drug data at EASD conference
• 2026-09-15 Berenberg upgrades Eli Lilly stock rating on obesity drug strength
• 2026-09-14 Eli Lilly has more than 30% of new patients on oral weight-loss meds: exec
• 2026-09-14 Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs
• 2026-09-14 Is This LLY Stock Dip Big Enough To Be Worth Buying?